![]() |
Truth is irrelevant
Am I closer to understanding why people go berserk after reading this paragraph in an article about Amgen? I think so. But if ever really get to the point of going berserk... I won't be able to move to do it.
Does this make your blood boil or what? In 1994, Amgen made its first acquisition - Synergen Inc., for $262 million through a cash tender offer. The acquisition gave Amgen the patent right to synthetic GDNF or Glial cell line-derived neurotrophic factor developed by Synergen. GDNF was thought to hold great promise for treating Parkinson's disease. However, the much-touted GDNF trial turned out to be a bust as the compound failed to demonstrate any clinical improvement after six months of use and on September 1, 2004, Amgen halted all clinical trials of GDNF. Amgen - Healthy Or Anemic RTT News - Williamsville,NY,USA The acquisition gave Amgen the patent right to synthetic GDNF or Glial cell line-derived neurotrophic factor developed by Synergen. GDNF was thought to hold ... |
Grrrrrrr
I'm to the point that I think some of us should buy a share of Amgen stock - attend the next shareholders' meeting and tell them to:
SELL the rights to GDNF !!! The sale would add to Amgen's coffers ... and help us!! |
All times are GMT -5. The time now is 08:04 AM. |
Powered by vBulletin Copyright ©2000 - 2025, Jelsoft Enterprises Ltd.
vBulletin Optimisation provided by
vB Optimise (Lite) -
vBulletin Mods & Addons Copyright © 2025 DragonByte Technologies Ltd.